and lupus therapies litifilimab and dapirolizumab pegol. Last month, the FDA ended a five-year drought in new therapies for ALS when it approved Amylyx' Relyvrio (sodium phenylbutyrate and ...

Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ETCompany ParticipantsTim Power - Head of IRChris Viehbacher ...

At this time, I'd like to welcome everyone to the Biogen fourth-quarter and full-year 2024 earnings call and business update. [Operator instructions] Today's conference is being recorded. Thank you. I ...

A lot is riding on Aduhelm follow-up lecanemab, which has been filed in the US and is heading for an FDA decision in January, along with other late-stage programmes like Sage Therapeutics ...

Diagnosis of AD is made largely by history but must include loss of memory and one or more of the following: aphasia, apraxia, agnosia, and disturbance in executive functioning (American ...

In England and Wales, MCC vaccine programs resulted in substantial herd immunity, as shown by reductions in serogroup C carriage prevalence and serogroup C disease in unvaccinated individuals ...